Q&A: A New Tool for Ensuring Genetic Privacy
Q&A: A New Tool for Ensuring Genetic Privacy
Gamze Gursoy and Mark Gerstein of Yale Medical School have developed a strategy for stripping identifying variants from functional genomic data, balancing privacy with utility.
Q&A: A New Tool for Ensuring Genetic Privacy
Q&A: A New Tool for Ensuring Genetic Privacy

Gamze Gursoy and Mark Gerstein of Yale Medical School have developed a strategy for stripping identifying variants from functional genomic data, balancing privacy with utility.

Gamze Gursoy and Mark Gerstein of Yale Medical School have developed a strategy for stripping identifying variants from functional genomic data, balancing privacy with utility.

23andMe
African American Genomes Yield Insight into Slavery Practices
African American Genomes Yield Insight into Slavery Practices
Amanda Heidt | Jul 23, 2020
A massive study finds that regional differences in how slaves were treated throughout the Americas are reflected in the DNA of present-day Americans of African descent.
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
Catherine Offord | Jul 9, 2019
Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?
Startups Plan the Health Data Gold Rush
Startups Plan the Health Data Gold Rush
Shawna Williams | Oct 1, 2018
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.
Opinion: Consumer DNA Testing Is Crossing into Unethical Territories
Opinion: Consumer DNA Testing Is Crossing into Unethical Territories
John D. Loike | Aug 16, 2018
Data don’t support many direct-to-consumer products, from telomere assessments to bespoke diets based on genetic sequences.
MyHeritage Account Data Compromised in “Cybersecurity Incident”
MyHeritage Account Data Compromised in “Cybersecurity Incident”
Catherine Offord | Jun 6, 2018
A security researcher found the email addresses and encrypted passwords of more than 92 million users of the genealogy site on a private server outside the company.
Companies to Help People Sell or Rent Out Their Health Data
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
Opinion: No, FDA Didn’t Really Approve 23andMe’s <em>BRCA</em> Test
Opinion: No, FDA Didn’t Really Approve 23andMe’s BRCA Test
Cecile Janssens | Mar 19, 2018
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
First Direct-to-Consumer BRCA Test Authorized by FDA
First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
The Rising Research Profile of 23andMe
The Rising Research Profile of 23andMe
Catherine Offord | Nov 30, 2017
An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.
FDA OKs Marketing of DTC Genetic Health-Risk Tests
FDA OKs Marketing of DTC Genetic Health-Risk Tests
Diana Kwon | Apr 7, 2017
23andMe customers can now receive information about genetic risk for diseases including Parkinson’s and celiac.
Pooling Consumer Genetic Data, Researchers ID Links to Depression
Pooling Consumer Genetic Data, Researchers ID Links to Depression
Alison F. Takemura | Aug 2, 2016
Access to data from thousands of genotyping customers helped scientists detect novel associations with the disorder across the genome.
23andMe Markets Genome Kits to Researchers
23andMe Markets Genome Kits to Researchers
Kerry Grens | Jul 14, 2016
Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.
Genetic Connections Among Human Traits
Genetic Connections Among Human Traits
Anna Azvolinsky | May 16, 2016
A study identifies genetic variants that are linked to multiple phenotypes.
Genetic Resilience
Genetic Resilience
Tanya Lewis | Apr 11, 2016
An analysis of the genomes of nearly 600,000 healthy individuals reveals a handful of people who appear resistant to certain genetic disorders.
GWAS IDs “Morning People”
GWAS IDs “Morning People”
Catherine Offord | Feb 3, 2016
In a large genome-wide association study, researchers from 23andMe locate 15 DNA regions associated with people’s preferences for early morning starts.
Following FDA OK, 23andMe to Expand Health Prediction
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens | Oct 21, 2015
The personal genomics firm is ramping up its suite of disease-related genetic tests.
23andMe Enters Drug Development
23andMe Enters Drug Development
Kerry Grens | Mar 12, 2015
The personal genomics firm announces plans to make medicines.
FDA OKs 23andMe Test
FDA OKs 23andMe Test
Kerry Grens | Feb 20, 2015
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
23andMe Partners with Pfizer
23andMe Partners with Pfizer
Jef Akst | Jan 13, 2015
The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.